Influenza Hemagglutinin (HA) Peptide: Precision Epitope Tag for Protein Detection and Purification

Executive Summary: The Influenza Hemagglutinin (HA) Peptide (sequence: YPYDVPDYA) is a synthetic, nine-amino-acid reagent used as an epitope tag for detection and purification of HA-tagged fusion proteins in molecular biology workflows (APExBIO). Its high purity (>98% by HPLC/MS) ensures consistent binding and elution in immunoprecipitation assays. The HA peptide competitively binds anti-HA antibodies to enable specific protein recovery (ap24534.com). Quantitative benchmarks confirm solubility in DMSO (≥55.1 mg/mL), ethanol (≥100.4 mg/mL), and water (≥46.2 mg/mL) under standard conditions. Proper storage at -20°C preserves activity and minimizes degradation. This reagent is cited in peer-reviewed research for robust protein interaction studies and translational applications (Dong et al., 2025).

Biological Rationale

The HA tag peptide is derived from the human influenza hemagglutinin (HA) protein, a viral envelope glycoprotein involved in host cell entry (Dong et al., 2025). In molecular biology, the HA tag sequence (YPYDVPDYA) is engineered into recombinant fusion proteins to enable specific recognition by anti-HA monoclonal antibodies. This system allows for detection, purification, and analysis of tagged proteins without altering their structure or function (cy5-5-nhs-ester.com). The short length of the HA tag reduces the risk of interfering with protein folding or activity, making it suitable for a wide range of protein-protein interaction and immunoprecipitation assays.

Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

The Influenza Hemagglutinin (HA) Peptide acts as a competitive ligand for anti-HA antibodies. In immunoprecipitation (IP) workflows, the synthetic HA peptide is added to elute HA-tagged fusion proteins from antibody-conjugated beads. The peptide's YPYDVPDYA sequence specifically mimics the epitope recognized by anti-HA antibodies, displacing the tagged protein through competitive binding (APExBIO). This approach enables gentle, targeted elution under physiological conditions, which preserves protein structure and complex formation (magnetic-co-ip.com). The peptide does not covalently modify proteins and is fully reversible by buffer exchange or washing.

Evidence & Benchmarks

• High purity (>98%) confirmed by HPLC and mass spectrometry enables reliable detection and elution in immunoprecipitation workflows (APExBIO).
• Solubility: DMSO (≥55.1 mg/mL), ethanol (≥100.4 mg/mL), water (≥46.2 mg/mL) at 20–25°C, facilitating compatibility with diverse buffers and protocols (APExBIO).
• Competitive elution of HA-tagged proteins demonstrated in vitro, enabling recovery of intact protein complexes from anti-HA beads (Dong et al., 2025).
• Tag sequence (YPYDVPDYA) is functionally orthogonal to most eukaryotic and prokaryotic proteomes, minimizing off-target detection (olaparib.net).
• Recommended storage: desiccated at -20°C; solutions are stable for short-term use (≤1 week) to prevent hydrolysis or bacterial growth (APExBIO).
• Used in advanced signaling studies to map protein complexes in the AKT/mTOR pathway, demonstrating compatibility with mechanistic cellular research (Dong et al., 2025).

Applications, Limits & Misconceptions

The HA peptide is widely used as an epitope tag for protein detection, purification, and protein-protein interaction studies in basic and translational research. Protocols typically employ the peptide for competitive elution in immunoprecipitation assays or as a blocking reagent in immunoassays (ap24534.com). Its small size facilitates use in live-cell imaging, immunocytochemistry, and co-immunoprecipitation (co-IP) experiments. However, several limitations must be considered:

Common Pitfalls or Misconceptions

• Not a universal elution reagent: The HA peptide only elutes proteins tagged with the YPYDVPDYA sequence; it does not work with other epitope tags (e.g., FLAG, Myc).
• Does not stabilize protein folding: The HA tag is not a solubility or folding enhancer; it does not prevent aggregation of inherently unstable proteins.
• Non-covalent interactions: The elution is based on competitive binding, not proteolytic cleavage or covalent modification.
• Storage limitations: Long-term peptide solutions may degrade or become contaminated; always prepare fresh aliquots and store desiccated at -20°C.
• Epitope accessibility issues: HA tag must be surface-exposed; buried or conformationally masked tags may not be efficiently detected or eluted by the peptide.

This article expands on precision workflows described in cy5-5-nhs-ester.com by providing new benchmarks and clarifying storage and compatibility boundaries; it also updates advanced troubleshooting guidance found at ap24534.com by detailing mechanistic applications in AKT/mTOR pathway studies.

Workflow Integration & Parameters

To use the Influenza Hemagglutinin (HA) Peptide (A6004 kit) in immunoprecipitation or protein purification workflows, dissolve the peptide in DMSO, ethanol, or water at the recommended concentration. Add the peptide to anti-HA antibody or bead complexes at a final concentration of 1–10 mM, depending on binding capacity and volume. Incubate at 4°C for 15–60 minutes to achieve competitive elution. Collect eluted fractions and analyze by SDS-PAGE, western blotting, or mass spectrometry. For optimal results, avoid repeated freeze-thaw cycles and limit storage of peptide solutions to less than one week (APExBIO).

For advanced applications such as mapping dynamic protein complexes or probing post-translational modifications in signaling pathways (e.g., AKT/mTOR), the HA peptide enables selective enrichment with minimal background (Dong et al., 2025). Protocol adaptation for high-throughput or magnetic bead-based platforms is supported, with documentation and troubleshooting resources available.

Conclusion & Outlook

The Influenza Hemagglutinin (HA) Peptide, available from APExBIO, is a validated, high-purity reagent for epitope tagging, immunoprecipitation, and protein interaction studies. Its robust competitive binding and solution stability enable reproducible workflows across molecular and cellular biology. Recent research confirms suitability for mapping complex signaling networks and supports ongoing innovation in translational proteomics (Dong et al., 2025). For detailed product specifications and ordering, visit the official Influenza Hemagglutinin (HA) Peptide page.